Skip to main content
OpenTrials
Completed

NCT Number: NCT06033313

Effects of Framing on Medication Beliefs, Intentions to Take Medication, Adherence, and Asthma Control

The goal of this study is to examine the effects of framed mobile messages on young adults' beliefs about their daily Inhaled Corticosteroids (ICS), intentions to take their ICS, adherence, and asthma control. College students (18-29 years) who owned a mobile phone and had a diagnosis of asthma with a prescription for an ICS will be recruited. Participants will be randomized to receive either gain- or loss-framed mobile messages three times per week for eight weeks. Outcomes including beliefs, intentions, adherence, and asthma control will be assessed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

18 year–29 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Auburn University

Auburn, Alabama, 36849, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A diagnosis of asthma
  • A prescription for an inhaled corticosteroid
  • Enrolled in college
  • Between 18-29 years of age
  • Owns a mobile phone

Exclusion criteria

  • Cannot read in english

Treatment and study plan

Negatively Framed text messages

Behavioral

Negatively Framed text messages delivered to participants three times per week for 8 weeks.

Positively Framed text messages

Behavioral

Positively Framed text messages delivered to participants three times per week for 8 weeks.

Primary outcomes

  1. Changes in Asthma control

    Time frame: Data collection at baseline, week 4, and week 8

    Asthma control as measured by the Asthma Control Test (minimum value=5, maximum value= 25) Questionnaire (scores of 20 and above indicate asthma control)

Secondary outcomes

  1. Changes in Medication Beliefs

    Time frame: Data collection at baseline and week 8

    Medication Beliefs as measured by the Beliefs about Medicines Questionnaire-Specific (This scale has two sub-scales : necessity (20- points) and concerns (20 points). A difference of necessity and concern scores shows the level of perceived necessity for the medication. Higher scores indicate higher perceived necessity for the medication.

  2. Intentions to take medication as prescribed

    Time frame: Data collection at baseline and week 8

    Intentions to take inhaled corticosteroids as prescribed as measured by an intentions scale (minimum score = 3, maximum score = 15; higher scores indicate greater intentions; the scale was tested in the study)

  3. Changes in Medication adherence

    Time frame: Data collection at baseline, week 4, and week 8

    Adherence to a daily dose of inhaled corticosteroid as measured by the Medication Adherence Report Scale for Asthma (MARS-A) (Minimum score = 10, maximum score = 50, higher scores indicate greater adherence)

Sponsors and collaborators

Lead sponsor

Auburn University

Other

Registry information

Official study title

Examining the Effect of Message Framing on Medication Beliefs, Intentions to Take Medications, Adherence to Medication, and Asthma Control Among College Students

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Sep 13, 2023
Registry last updated
Sep 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.